Lipella Pharmaceuticals (LIPO) Competitors $2.64 -0.31 (-10.51%) (As of 11/13/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends LIPO vs. WENA, TSBX, INDP, TRIB, HCWB, AYTU, PHXM, KPRX, SNTI, and EGRXShould you be buying Lipella Pharmaceuticals stock or one of its competitors? The main competitors of Lipella Pharmaceuticals include ANEW Medical (WENA), Turnstone Biologics (TSBX), Indaptus Therapeutics (INDP), Trinity Biotech (TRIB), HCW Biologics (HCWB), Aytu BioPharma (AYTU), PHAXIAM Therapeutics (PHXM), Kiora Pharmaceuticals (KPRX), Senti Biosciences (SNTI), and Eagle Pharmaceuticals (EGRX). These companies are all part of the "pharmaceutical products" industry. Lipella Pharmaceuticals vs. ANEW Medical Turnstone Biologics Indaptus Therapeutics Trinity Biotech HCW Biologics Aytu BioPharma PHAXIAM Therapeutics Kiora Pharmaceuticals Senti Biosciences Eagle Pharmaceuticals ANEW Medical (NASDAQ:WENA) and Lipella Pharmaceuticals (NASDAQ:LIPO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends. Does the MarketBeat Community believe in WENA or LIPO? Lipella Pharmaceuticals received 1 more outperform votes than ANEW Medical when rated by MarketBeat users. CompanyUnderperformOutperformANEW MedicalN/AN/ALipella PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo Votes Do insiders and institutionals believe in WENA or LIPO? 20.1% of ANEW Medical shares are held by institutional investors. Comparatively, 74.3% of Lipella Pharmaceuticals shares are held by institutional investors. 2.0% of ANEW Medical shares are held by insiders. Comparatively, 37.0% of Lipella Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts rate WENA or LIPO? Lipella Pharmaceuticals has a consensus target price of $16.00, indicating a potential upside of 506.06%. Given Lipella Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Lipella Pharmaceuticals is more favorable than ANEW Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ANEW Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lipella Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, WENA or LIPO? ANEW Medical has higher earnings, but lower revenue than Lipella Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioANEW MedicalN/AN/AN/AN/AN/ALipella Pharmaceuticals$450K7.10-$4.62M-$4.80-0.55 Is WENA or LIPO more profitable? ANEW Medical has a net margin of 0.00% compared to Lipella Pharmaceuticals' net margin of -817.16%. ANEW Medical's return on equity of 0.00% beat Lipella Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ANEW MedicalN/A N/A N/A Lipella Pharmaceuticals -817.16%-172.07%-141.17% Does the media prefer WENA or LIPO? In the previous week, Lipella Pharmaceuticals had 4 more articles in the media than ANEW Medical. MarketBeat recorded 5 mentions for Lipella Pharmaceuticals and 1 mentions for ANEW Medical. ANEW Medical's average media sentiment score of 0.75 beat Lipella Pharmaceuticals' score of 0.48 indicating that ANEW Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ANEW Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lipella Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryLipella Pharmaceuticals beats ANEW Medical on 8 of the 12 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Lipella Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIPO vs. The Competition Export to ExcelMetricLipella PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.19M$6.77B$5.16B$8.94BDividend YieldN/A8.07%5.04%4.03%P/E Ratio-0.558.44108.6316.30Price / Sales7.10399.721,296.7392.25Price / CashN/A49.2239.4636.42Price / Book0.619.296.435.98Net Income-$4.62M$154.14M$115.02M$225.08M7 Day Performance5.43%-3.63%-0.93%0.04%1 Month Performance-19.26%5.81%3.49%4.55%1 Year Performance-71.30%38.55%37.18%27.70% Lipella Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIPOLipella Pharmaceuticals3.6765 of 5 stars$2.64-10.5%$16.00+506.1%-72.3%$3.19M$450,000.00-0.554Short Interest ↓WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AUpcoming EarningsGap UpTSBXTurnstone Biologics3.7342 of 5 stars$0.53-7.0%$2.13+297.9%-70.3%$12.35M$19.31M-0.1682Earnings ReportUpcoming EarningsNews CoverageGap DownINDPIndaptus Therapeutics3.2089 of 5 stars$1.18+2.6%$8.50+623.4%-47.1%$11.99MN/A-0.696Analyst ForecastShort Interest ↑News CoverageGap UpTRIBTrinity Biotech1.9507 of 5 stars$1.55-3.7%N/A-26.2%$11.81M$56.83M-0.57480Short Interest ↓Gap DownHCWBHCW Biologics1.8352 of 5 stars$0.31-3.1%N/A-78.0%$11.72M$2.84M-0.3040Short Interest ↓Positive NewsGap DownAYTUAytu BioPharma1.2647 of 5 stars$1.75+0.6%N/A-34.6%$10.73M$81.00M-0.61160Short Interest ↓News CoverageGap UpPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049News CoverageKPRXKiora Pharmaceuticals3.6135 of 5 stars$3.44-5.0%$10.00+190.7%-37.1%$10.32MN/A0.0010Earnings ReportAnalyst ForecastShort Interest ↑News CoveragePositive NewsGap UpSNTISenti Biosciences0.9427 of 5 stars$2.25-0.9%N/A-48.2%$10.31M$2.56M-0.184Positive NewsEGRXEagle Pharmaceuticals1.6834 of 5 stars$0.75-16.7%N/A-92.1%$9.74M$316.61M0.00134Analyst ForecastNews Coverage Related Companies and Tools Related Companies WENA Competitors TSBX Competitors INDP Competitors TRIB Competitors HCWB Competitors AYTU Competitors PHXM Competitors KPRX Competitors SNTI Competitors EGRX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIPO) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipella Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIPO Stock Alerts